Indiana Journal of Global Legal Studies

Volume 28

Indiana Journal of Global Legal
Studies

Issue 2

Article 8

Summer 8-1-2021

I Just Took a DNA Test—Turns Out, I'm 100% Breaching My Donor
Anonymity Contract: Direct-to-Consumer DNA Testing and
Parental Medical-Decision-Making
Morgan C. York
Indiana University Maurer School of Law, mcyork@iu.edu

Follow this and additional works at: https://www.repository.law.indiana.edu/ijgls
Digital
Part of the Comparative and Foreign Law Commons, Law and Society Commons, and the Medical
Commons
Jurisprudence Commons
Network
Logo

Recommended Citation
York, Morgan C. (2021) "I Just Took a DNA Test—Turns Out, I'm 100% Breaching My Donor Anonymity
Contract: Direct-to-Consumer DNA Testing and Parental Medical-Decision-Making," Indiana Journal of
Global Legal Studies: Vol. 28 : Iss. 2 , Article 8.
Available at: https://www.repository.law.indiana.edu/ijgls/vol28/iss2/8

This Note is brought to you for free and open access by
the Maurer Law Journals at Digital Repository @ Maurer
Law. It has been accepted for inclusion in Indiana Journal
of Global Legal Studies by an authorized editor of Digital
Repository @ Maurer Law. For more information, please
contact rvaughan@indiana.edu.

Footer logo

I Just Took a DNA Test-Turns Out, I'm 100%
Breaching My Donor Anonymity Contract:
Direct-to-Consumer DNA Testing and
Parental Medical-Decision-Making
MORGAN CATHERINE YORK*
INTRODUCTION

The holiday season of 2018 was frightful for Danielle Teuscher. Like
some parents, Danielle decided to genetically test her five-year-old
daughter, Zoe. 1 Unlike some parents, however, Danielle used a sperm
donor to conceive Zoe. 2 Danielle opted to test her donor-conceived
daughter with 23andMe's health and ancestry kits to learn more about
Zoe's heritage and health risks, but she faced serious legal
repercussions from NW Cryobank, the sperm bank that provided the

* J.D. Candidate, Indiana University Maurer School of Law, 2021. This note and the
supporting research would not have been possible without the knowledge and support of
Professor Jody Lyne6 Madeira. Lectures in her course "Reproduction, Childhood, and the
Law" sparked my interest in this area, but her enthusiasm and expertise helped me
develop this note. I am also grateful to the entire staff of the Indiana Journal of Global
Legal Studies for their assistance and feedback throughout the revision process. Finally, I
owe a deep gratitude to Emily Baert and Zachary Peifer for looking over numerous drafts
of my work and encouraging me throughout many late nights. Any remaining errors are
my own.
1. Nila Bala, Why Are You Publicly Sharing Your Child's DNA Information?, N.Y.
TIMES (Jan. 2, 2020), https://www.nytimes.com/2020/01/02/opinion/dna-test-privacychildren.html.
2. Zoe was conceived with sperm donated by Donor #2744, who was registered as an
"Open ID" donor-a donor who is open to contact when his donor-conceived offspring
reaches eighteen years of age. See Ellen Trachman, Beware of the Home DNA Test! Mom
Strikes Back Against Sperm Bank, ABOVE THE LAW (Oct. 23, 2019, 1:42 PM),
https://abovethelaw.com/2019/10/beware-of-the-home-dna-test-mom-strikes-back-againstsperm-bank/. Danielle's choice of Donor #2744 was largely in part because he was an
"Open ID" donor and was "Retired," meaning he had stopped donating and that there was
only a limited supply of his gametes available. Complaint para. 26, Teuscher v. CCBNWB, LLC, 437 F.Supp. 3d 849 (E.D. Wash. 2020) (No. 19-CV-00204).
3. Test Info, 23ANDME, https://www.23andme.com/test-info/ (last visited Mar. 12,
2021).
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sperm. 4 Zoe's 23andMe results included a match to her paternal
grandmother on 23andMe's database. 5 Zoe's paternal grandmother was
listed as "receptive to contact" on the site, so Danielle sent a short
message through 23andMe's portal indicating Zoe's relatedness and an
openness to connect. Despite the paternal grandmother's listing as open
to contact, Danielle received a cease and desist letter from NW
Cryobank due to her alleged breaches of contract. 7 Further, NW
Cryobank sought financial penalties amounting to $20,000.8 Tis the
season?

Specifically, Danielle's alleged breaches included (1) seeking the
identity of the donor and (2) contacting the donor's mother. 9 In addition
to financial penalties, NW Cryobank stated it would deny her access to
four vials of sperm (for which she paid) that she had hoped to use to
conceive another child who would be a genetic match to Zoe. 10 Further,
4. See Trachman, supranote 2.
5. Gregory Loy, Taking a Stand Against an Unregulated Industry, SEVERANCE MAG.
(Jan. 21, 2020), https://severancemag.com/taking-a-stand-against-an-unregulated-industry/.
6. Id.
7. Jacqueline Mroz, A Mother Learns the Identity of Her Child's Grandmother. A
Sperm Bank Threatens to Sue., N.Y. TIMES (Feb. 16, 2019), https://www.nytimes.com/
2019/02/16/health/sperm-donation-dna-testing.html (stating that Ms. Teuscher breached
her contract by using the results from the ancestry portion of 23andMe to contact the
mother of donor used for Ms. Teuscher's child).
8. Id.; see also Complaint, supra note 2, para. 70.
9. On January 12, 2019, Danielle Teuscher received a Cease and Desist Letter from
general counsel at NW Cryobank. The letter stated:
Your attempt to seek the identity of the Donor and then to contact the
Donor's mother through 23andMe is, in each case, a flagrant violation
of the Agreement (the Customer Agreement). Under Section VIII of the
Agreement (Customer Agreement), NWCryobank (sic) is entitled to
liquidated damages in the amount of $10,000 for each act in violation
of Section VIII. At this point, we are entitled to seek $20,000 in
liquidated damages from you $10,000 for seeking the identity, $10,000
for initiating contact).
Upon further investigation, we may be entitled to addtional [sic]
monetary damages if you have used other ancestry DNA programs,
facial recognition tools on the internet or any other means, directly or
indirectly, to contact or seek the identity of the Donor. We will seek a
restraining order or injunction if you continue with this course of
action in any maner [sic] . ...

Moreover, we hereby notify you that as a direct result of your flagrant
and material breach of the Agreement we are revoking your right to
receive the four (4) [sic] additional vials of Donor's sperm that you
purchased. No refund will be given.
Complaint, supranote 2, para. 70.
10. The cease and desist letter was wrong; Danielle Teuscher had five vials of
purchased sperm stored at NW Cryobank. Trachman, supra note 2; see also Mroz, supra
note 7.
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the company redesignated the status of Zoe's donor from "open ID" to
"anonymous," 11 effectively denying Danielle access to medical
information updates from both the donor and parents of other children
conceived from that donor's sperm. 12
Danielle is not the only NW Cryobank consumer impacted by this
particular situation-since NW Cryobank sent the cease and desist
letter, the company has disabled access to its donor sibling registry,13 an
action that harms all NW Cryobank consumers and conceived children
"by preventing them from being able to connect with relatives and make
other important connections for the children's wellbeing [sic]." 14
Though few may consider this to be a justified consequence for
Danielle's alleged breach, it is important to note that the click-wrap
agreement Danielle signed did not include a provision giving NW
Cryobank the right to take away Danielle's purchased gametes; the
agreement only permitted NW Cryobank to cease storing gametes and
to destroy them if payment was not received. 15 Further, the agreement
included other provisions biased towards NW Cryobank, like one
specifying that any attorneys' fees spent by NW Cryobank on any court

action shall be paid by the customer, which is against Washington
law. 16 Another issue at the forefront of Danielle's legal issues with NW
Cryobank is whether she-and other parents of donor-conceived
children-had adequate informed consent before she signed this clickwrap agreement. 17
11. Complaint, supra note 2, para. 3. NW Cryobank's website lists three types of sperm
donor options: (1) Anonymous Sperm Donors-who have been promised that "[p]arents,
recipients, or donors cannot initiate any communication"; (2) Open to Communication
Sperm Donors-who "have agreed to a minimum of one communication with offspring who
are at least 18 years old," and NW Cryobank "will not break anonymity unless both
parties request it"; and (3) ID Disclosure Sperm Donors-who have agreed to provide
identifying information to donor-conceived adults when they turn 18 years old. Sperm
Donor Types, NW CRYOBANK, https://www.nwcryobank.com/sperm-donor-types/ (last
visited Mar. 12, 2021). However, NW Cryobank requires donor-conceived adults to sign a
non-disclosure agreement where they agree not to share this information with other
offspring, on message boards, social media, etc. Id. Refusal to sign the agreement results
in no release of information at all. Id.
12. Loy, supra note 5; see also Trachman, supra note 2.
13. Loy, supra note 5.
14. Id.
15. The agreement contained a space for Danielle Teuscher "to 'click the box' and,
when she electronically clicks on the box, the computer program will insert a check mark
under each section of the Customer Agreement." Complaint supranote 2, paras. 37, 39.
16. Loy, supra note 5.
17. See Margaret Jane Radin, Boilerplate Today: The Rise of Modularity and the
Waning of Consent, 104 MICH. L. REv. 1223, 1231 (2006) ('Consent is fictional when
almost all of us click on-screen boxes affirming that we have read and understood things
we have not read and would not understand if we did.").
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Now, with an increased interplay between direct-to-consumer DNA
testing and advanced reproductive methods, the position in which
Danielle finds herself is seemingly becoming more common. Following
the cease and desist letter, parents of donor-conceived children have
reason to fear-the investigation of one's donor-conceived child's genetic
history may result in similar cease and desist letters, large financial
penalties, denials of access to donor medical updates and community
forums concerning related children, and denials of future access to
gametes. 18
In the era of widespread availability of direct-to-consumer DNA
testing, some facilities in the industry of fertility medicine have
acknowledged that the promise of anonymity may inevitably be shortlived. 19 Cryos International, one of the largest sperm and egg banks in
the world, has acknowledged that gamete donors can be identified
through direct-to-consumer DNA testing. 20 While Cryos International
still offers sperm donors the option of being an "ID Release" or a "NonID Release" sperm donor, the company makes direct statements
regarding the possibility of all donors being found with DNA analysis
and genetic testing services. 21 NW Cryobank, on the other hand, has
chosen to retaliate against its consumers instead of accepting that
advances in technology have reshaped the capacity of accessible health
information. Further, NW Cryobank still offers the sperm donors the

18. Loy, supra note 5.
19. ID
Release
or
Non-ID
Release
Sperm
Donor?,
CRYOS
INT'L,
https://www.cryosinternational.com/en-US/us-shop/become-a-donor/become-a-spermdonor/how-to-become-a-sperm-donor/id-release-or-non-id-release-sperm-donor/ (last visited
Mar. 12, 2021).
20. Id. Cryos International website states:
While Cryos will never release your information, there is a chance of
being identified through familial DNA testing. Sperm contains DNA
and therefore, there will always be a chance that donors, clients and
donor children can be found via a DNA analysis or genetic testing
service. As a Non-Id Release sperm donor, we are unable to protect you
from being found in this manner. You and all donors should be aware
that they could be found in the future through genetic testing. As a
Non-Id Release donor, Cryos guarantees that we will never disclose
your personal information to anyone.
Id.
21. Id. Donor anonymity can also be an issue for egg donors, but less so. "Eggs
harvested from women are typically done in a more open manner, with recipients given
identifying information about the donors from the outset, or when the child turns 18."
Meghana Keshavan, 'There's No Such Thing as Anonymity': With Consumer DNA Tests,
Sperm Banks Reconsider Long-held Promises to Donors, STAT (Sept. 11, 2019),
https://www.statnews.com/2019/09/1 1/consumer-dna-tests-sperm-donor-anonymity/.
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option to be "anonymous," despite its current predicament with Danielle
Teuscher. 22
Since the 1800s, donors of reproductive materials have been
afforded the right to remain anonymous, largely because of the stigma
attached to infertility and the lack of advanced technology to gain access
to the information.23 Additionally, many parents were told there would
be "irreparable harm" to their marriages and to their donor-conceived
children if this information was given to them. 24 Several countries still
offer donor anonymity, while others have dispelled this notion. 25
Anonymity regulations serve as barriers to accessing a donor-conceived
child's genetic information because a child's genetic information is often
used to trace genetic relatives, including donors. 26 It seems that parents
in many countries struggle to gain access to their donor-conceived
child's genetic information unless the donor specifically consents. With
the rise of direct-to-consumer DNA testing, however, companies like
23andMe have forced a reckoning on the fertility industry as parents
circumvent various anonymity regulations to seek health information
about their child.27

Recently, access to a person's genetic information has become
almost mainstream due to the availability and affordability of direct-toconsumer DNA testing in nearly every country. 28 The Center for
Genetics and Society found that, as of 2019, more than twenty-six
million people throughout the world have taken some kind of direct-to22. See Sperm Donor Policies, NW CRYOBANK, https://nwsperm.com/about/spermdonor-policies (last visited May 8, 2020).
23. See Sperm Donors Have Been Promised Anonymity for a Century. Then Came
23andMe., ADVISORY BD. (Sept. 16, 2019), https://www.advisory.com/daily-briefing/2019/
09/16/sperm-donor [hereinafter Sperm Donors PromisedAnonymity].
24. Id.
25. Glenn Cohen et al., Sperm Donor Anonymity and Compensation: An Experiment
with American Sperm Donors, 3 J.L. & BIOSCIENCES, 468, 469-73 (2016). Countries that
currently allow donor anonymity include Canada, Cyprus, France, Japan, Spain, Belgium,
Denmark, and the United States. Sperm Donation Laws by Country, WIKIPEDIA,
http://en.wikipedia.org/w/index.php?title=Spermdonationlawsbycountry&oldid=65414
8051 (last visited May 21, 2020). Countries that do not allow donor anonymity include
Australia, Austria, Germany, Netherlands, New Zealand, Norway, Sweden, Switzerland,
and the United Kingdom. Id.
26. Understanding the Pros and Cons of Genetic Testing, UNIV. ILL. CHI.,
https://healthinformatics.uic.edu/blog/pros-and-cons-of-genetic-testing/
(last visited Mar.
12, 2021).
27. See Sperm Donors PromisedAnonymity, supra note 23.
28. See Antonio Regalado, More Than 26 Million People Have Taken an At-home
Ancestry Test, CTR. FOR GENETICS AND SOC'Y, https://www.geneticsandsociety.org/article/
more-26-million-people-have-taken-home-ancestry-test [hereinafter 26 Million People];
LIzzo, Truth Hurts, on CUz I LOVE YOU (Atlantic Records 2017) (including lyrics in which
popular singer and rapper, Lizzo, mentions DNA testing).
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consumer DNA test; further, "[a]s many people purchased consumer
DNA tests in 2018 as in all previous years combined." 29 Each year
around the holidays, the price of popular DNA testing kits are marked
down, which allows greater access to genetic information. 30 Due to the
accessibility and increased popularity of direct-to-consumer DNA
testing kits, promises of donor anonymity are disingenuous and possibly
fraudulent. Parents of a donor-conceived child can receive information
about their child's genes by using direct-to-consumer DNA testing and
entirely circumvent (or breach) anonymity provisions that protect the
identity of the donor.
As a matter of public policy, numerous countries have expressed
their recognition of the importance of genetic testing as it relates to
health. The National Human Genome Research Institute, in connection
with the U.S. Office of the Surgeon General, stated that, "[t]racing the
illnesses suffered by your parents, grandparents and other blood
relatives can help your doctor predict the disorders to which you may be
at risk, and help you take action to keep you and your family healthy."31
Further, officials from the United Kingdom's Medicines and Healthcare
Products Regulatory Agency say "they support the use of commercial
genomic testing to help patients become better informed about their
health and future medical decisions." 32
To add a level of complexity, the United States FDA now regulates
certain kits distributed by 23andMe as "medical devices," 33 seemingly
placing DNA testing in the realm of healthcare. This classification
suggests that DNA testing is akin to a medical procedure and choosing
to take a DNA test is a medical choice. In many countries, like the
United States, parents maintain the right to make medical decisions for
their minor children, including when to opt in or opt out of a medical
procedure. 34 As a result, the regulation of certain 23andMe kits as
medical devices introduces a new question: can parents bypass their
29. See 26 Million People, supra note 28.
30. See Justin Jaffe, Best DNA Tests for 2021: AncestryDNA vs. 23andMe and More,
CNET (Jan. 11, 2021, 5:15 PM) https://www.cnet.com/health/best-dna-test-for-2021ancestrydna-vs-23andme-and-more/.
31. Family Health History for Patients and Family, NAT'L HUM. GENOME RES. INST.,
https://www.genome.gov/es/node/82056 (last updated Oct. 6, 2020).
32. Jessica Firger, U.K Approves Sales of 23andMe Genetic Test Banned in U.S., CBS
NEWS (Dec. 3, 2014, 5:50 AM), https://www.cbsnews.com/news/23-and-me-genetic-test-ukapproves-sale-banned-in-us/.
33. FDA Authorizes First Direct-to-Consumer Test for Detecting Genetic Variants That
May Be Associated with Medication Metabolism, FDA (Oct.
31,
2018),
http://www.fda. gov/news-events/press-announcements/fda-authorizes-first-directconsumer-test-detecting-genetic-variants-may-be-associated-medication.
34. See generally Parham v. J.R., 442 U.S. 584 (1979) (holding that parents retain a
substantial role in decision-making and act in the best interest of the child).
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jurisdiction's regulations on donor anonymity by categorizing the DNA
test as a "medical decision" for their child and thus within their
parental purview?

The answer to this increasingly common question depends on
numerous factors, including the jurisdiction, the rationale for testing
the donor-conceived child, the donor's classification, the anonymity
agreement, public policy, and more. Though the interplay between
direct-to-consumer DNA testing and reproductive
regulations
concerning donor anonymity is complex, this note advocates for parents'
rights to test their donor-conceived minor children by classifying this act
as a medical decision.
Part I of this note provides a brief history of assisted reproductive
technology and its increased use throughout the world, illustrating the
growing number of donor-conceived children and the related importance
of knowing

genetic

information.

Part

I also

surveys

regulations

concerning donor anonymity in the United States and the United
Kingdom to illustrate different jurisdictions' approaches to the
regulation of donor anonymity. This note uses the United Kingdom as a
model of countries that have prohibited sperm donor anonymity. Part II
of this note discusses direct-to-consumer DNA testing, specifically
23andMe's products. This note selects 23andMe as the direct-toconsumer company for its analysis because of the company's dominance
in the global market and the regulation of certain kits as "medical
devices," 35 which suggests parents' rights to have this test performed on
their minor children. Part III of this note explores parental decisionmaking abilities as they relate to medical decisions concerning minors.
Part IV of this note discusses the interplay between donor anonymity
and DNA testing, both in the United States and the United Kingdom.
The conclusion of this note discusses possible solutions for the issues
presented
by regulations
concerning
donor-conceived
genetic
information. It also highlights the benefits of allowing access to genetic
information of donor-conceived individuals, specifically by allowing
parents to genetically test their donor-conceived children. Ultimately,
the analysis concludes that donor anonymity is no longer feasible.
Instead, this note suggests countries continue to adopt and amend
regulations that enable donor-conceived individuals to have access to
their own genetic information without fear of redress against them, or
their parents.
35. See Justin Jaffe, Best DNA Test in 2020: 23andMe us. AncestryDNA and More,
CNET, https://www.cnet.com/health/best-dna-test-in-2020-23andme-vs-ancestrydna-andmore/ (last updated Dec. 19, 2020, 13:37 PM); Lists of Direct-To-Consumer Tests with
Marketing Authorization, FDA, http://www.fda.gov/medical-devices/vitro-diagnostics/
direct-consumer-tests#list (last visited Dec. 15, 2019).
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I. BACKGROUND INFORMATION

Part I of this note begins with background information about
assisted reproductive technology (ART)-namely, the types of
procedures and their increasing usage across the world. Next, it outlines
various global regulations that impact how reproductive materials are
sent to receiving countries and which individuals may receive those
reproductive materials. Collectively, this information supports the claim
that ART is increasing in usage across the world and impacting more
people as time progresses. Finally, Part I discusses the basic approaches
taken to regulate donor anonymity. Part I concludes with an overview of
donor anonymity regulations in the United States and United Kingdom.
Assisted Reproductive & Donor Anonymity
Assisted Reproduction Technology
ART refers to medical technology that aims to result in pregnancy
through means other than sexual intercourse.36 ART involves a variety
of different medical procedures where the egg, sperm, or embryo are
handled outside the body.37 ART does not include instances where only
sperm is handled or procedures in which women take medication solely
to stimulate reproductive functions, however. 38 The most common
reproductive
procedures
currently utilized
include
artificial
insemination 39 and in vitro fertilization (IVF).40 ART has the ability to
"promote new forms of equality for people who can't conceive or gestate
due to age, health, sexual orientation, the trauma of past pregnancy, or
the risk of transmitting disease."4 1 Others are able to use their own
36. Model Act Governing Assisted Reproductive Technology § 102(2) (2008). Examples
of ART include intrauterine insemination, egg donation, embryo donation, in vitro
fertilization, embryo transfer, and intracytoplasmic sperm injection. See generally
CHARLES P. KINDREGAN, JR. & MAUREEN MCBRIEN, ASSISTED REPRODUCTIVE
TECHNOLOGY: A LAWYER'S GUIDE TO EMERGING LAW AND SCIENCE (1st ed. 2006) (listing

&

examples of assisted reproductive technologies).
37. See JUDITH DAAR, REPRODUCTIVE TECHNOLOGIES AND THE LAW 7 (2d ed. 2013).
ART involves the handling of both sperm and egg-it takes two to tango.
38. What is Assisted Reproductive Technology?, CTRS. FOR DISEASE CONTROL
PREVENTION (Oct. 8, 2019), https://www.cdc.gov/art/whatis.html.
39. DAAR, supra note 37, at 7. This procedure involves introducing sperm into the
woman's reproductive tract using an injection device. Id.
40. Id. This procedure involves surgically removing eggs from a woman's ovaries and
combining them with sperm in a controlled setting. Id. The resulting product, the embryo,
is placed in the woman's uterus. See id.
41. DOV FOx, BIRTH RIGHTS AND WRONGS: HOW MEDICINE AND TECHNOLOGY ARE
REMAKING REPRODUCTION AND THE LAW 16 (2019).
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healthy reproductive materials at a later date with technology that
enables cryopreserving gametes. 42

The advancement of reproductive technology has benefitted
individuals throughout the world. Nearly forty years after the birth of
Louise Brown, the world's first "test-tube baby," the European Society of
Human Reproduction and Embryology estimates that more than eight
million babies have been born with the assistance of ART. 43 The number
of donor-conceived individuals in the world continues to increase as
more people opt to use reproductive technology and ARTs success rates
continue to stabilize. 44
Global Nature of Reproductive Technology
With current reproductive technology, "making a baby can be a
global affair." 45 Advancements in technology have enabled global
interaction with reproductive material used in these services-perhaps
most noticeably with the ability to ship sperm, eggs, ovarian tissue, and
embryos to fertility clinics and medical laboratories internationally. 46
The egg could come from a woman in Mexico, the sperm from a man in
Canada, and the surrogate herself might live in Denmark-the
prospects are infinite. 47

The varying laws and costs applicable to reproductive procedures
and technologies in countries create incentives for taking advantage of
porous international borders. 48 For instance, surrogacy for pay is legal
in certain jurisdictions within the United States, 49 but the process can

42. Cryopreservation refers to a process by which gametes or embryos are treated and
then frozen for potential future use. See generally KINDREGRAN & MCBRIEN, supra note 36
(describing commonly used ART terminology).
43. European Soc'y of Human Reprod. and Embryology, More Than 8 Million Babies
Born from IVF Since the World's First in 1978, SCI. DAILY (July 3, 2018),
https://www.sciencedaily.com/releases/2018/07/180703084127.htm.
44. See Vitaly A. Kushnir et al., Systematic Review of Worldwide Trends in Assisted
Reproductive Technology 2004-2013, 15 REPROD. BIOLOGY AND ENDOCRINOLOGY 1, fig. 1,
fig.3 (2017), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223447/.
45. Sarah Zhang, Inside the Hidden Global Supply Chainfor Frozen Sperm, Eggs, and
Embryos, WIRED (Apr. 25, 2016 7:00 AM), https://www.wired.com/2016/04/inside-hiddenglobal-supply-chain-frozen-sperm-eggs-embryos/.
46. Worldwide CourierProvidingSpecialist Service in Cryogenically Frozen Transfer of
Sperm, Eggs, Embryos and Cells, IVF COURIERS, https://www.ivfcouriers.com (last visited
Mar. 12, 2021); see also Peter Nagy, Is It Safe to Ship CryopreservedEggs (and Embryos)?,
FERTILITY IQ, https://www.fertilityiq.com/topics/egg-freezing/is-it-safe-to-ship-cryopreservedeggs-and-embryos (last visited Dec. 12, 2019).
47. Zhang, supra note 45.
48. See id.
49. Id. New York is restrictive with surrogacy, whereas California is permissive. Id.
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be prohibitively expensive. 50 Instead, some people look abroad for
cheaper alternatives, with less expensive reproductive materials found
in "South Africa, Cyprus, Spain, or Ukraine." 51
Varying reproductive regulations also limit the potential recipients
of reproductive materials and procedures. After utilizing IVF, a woman
in northern Italy was recently denied the ability to register her donorconceived son at the public records office due to strict Italian laws that
limit fertility treatments to "stable heterosexual couples." 52 This
mother's story illustrates yet another reason individuals participate in
the global market in furtherance of their goals to become parents:
opposition to same-sex couples and singles. 53 Like Italy, France does not
recognize children born to same-sex couples through reproductive
technology, specifically artificial insemination. 54
The regulations for shipping reproductive materials depend on the
shipping origin and destination. For instance, when shipping sperm

internationally, receiving countries may require different kinds of
documentation about the nature of the sperm they receive. 55 When
shipping sperm internationally, it is common for some regions to charge

import and export fees, which adds expense. 56 These fees are commonly
used to finance a medical examination of the sperm to verify that it is
free from disease. 57 Additionally, some countries restrict sperm imports
to a few allotted countries. 58 Kathryn Kaycoff, the president of the
Agency for Surrogacy Solutions, describes a case she is currently
working on:

50. See, e.g., Costs of Surrogacy in the USA, AM. FERTILITY SERVS.,
https://americanfertility.com/costs-surrogacy-usa/ (last visited Mar. 12, 2021).
51. Id.
52. Lesbian Mums Can't Register Baby in Italy, BBC (Apr. 19, 2018),
https://www.bbc.com/news/world-europe-43823692.
53. Id. In 2016, Italy passed a law that recognizes civil unions between same-sex
couples; however, fertility treatments are still only provided for "stable heterosexual
couples" that can prove clinical infertility, rather than social infertility due to sexual
orientation. Id.; see also John A. Robertson, Gay and Lesbian Access to Assisted
Reproductive Technology, 55 CASE W. RES. L. REv. 323 (2004) (exploring reproductive
technology and same-sex accessibility).
54. Matt Baume, France Is Running Out of Sperm, OUT (Sept. 24, 2019 12:09 PM),
https://www.out.com/news/2019/9/24/france-running-out-sperm.
55. Alex Tree, What Are the Regulations for Shipping Sperm?, WISEGEEK,
https://www.wisegeek.com/what-are-the-regulations-for-shipping-sperm.htm (last updated
Dec. 1, 2020).
56. Id.
57. Id.
58. Id.
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[H]er client is trying to export frozen embryos to the US
for surrogacy. Surrogacy for pay is illegal in Australia,
and the clinic with the current embryos objects to
transporting them to the US for paid surrogacy. So now,
they're trying to get it shipped to a second Australian
clinic that will in turn ship it to the US. 59

When shipping reproductive materials, the frozen cells need to be
cryogenically cold, minus 240 degrees Fahrenheit to be exact. 60 Kimball
Pomeroy, an embryologist with the World Egg Bank, explains that if
reproductive material reaches above even minus 184 degrees
Fahrenheit, it can restart some of the cellular processes, destroying
viability. Further, if the eggs warm under the wrong conditions, razor-

like ice crystals can form and ruin the prospects of using the egg. 61
Frozen reproductive material can be removed from liquid nitrogen tanks
and placed in shipping dewars, or frozen containers, to stabilize a
freezing temperature. 62 To bypass international aircraft regulations
concerning liquid nitrogen, the dewars contain retention foam that acts
like a sponge, absorbing liquid nitrogen while releasing only vapor
nitrogen during flight.63 Throughout transport, this dewar can maintain

a stable, low temperature for over a week, 64 enabling frozen
reproductive materials to survive the longest flight in the world-the
United States to Singapore-at nearly nineteen hours. 65
Recent statistics highlight the popularity of outsourcing various
elements in reproductive technology. For example, "[i]n the UK,
approximately one-third of licensed sperm donation uses donor sperm
imported from abroad, principally from Denmark and the USA."66 As
donor sperm, eggs, and embryos are imported into different countries
59. Zhang, supra note 45.
60. See id.
61. Id.; see also Tree, supra note 55. ('When shipping sperm with liquid nitrogen, the
sperm is good for more than a week. On the other hand, dry ice is not nearly as cool as
liquid nitrogen and should be used to ship sperm only to a nearby location. Dry ice can
safely store sperm for up to one day, in which case it cannot be transferred to a liquid
nitrogen container, but instead used by a medical professional the same day. If the sperm
thaws during shipment, it is no longer usable for insemination purposes.").
62. See Nagy, supra note 46.
63. Id.
64. Id.
65. Eric Rosen, The 2019 List of the Longest Flights in the World, FORBES (Jan. 2,
2019), https://www.forbes.com/sites/ericrosen/2019/01/02/the-2019-list-of-the-longest-flightsin-the-world/#76a335cc550b.
66. Joyce C. Harper et al., The End of Donor Anonymity: How Genetic Testing is Likely
to Drive Anonymous Gamete Donation Out of Business, 31 HUM. REPROD. 1135, 1136
(2016).
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for use, the donations technically must follow the laws and regulations
of the country where the donations are received, 67 but this is easily
complicated. For example, in the United Kingdom, donors must follow
regulations restricting anonymity, but these regulations only apply to

donors as they give reproductive materials to fertility clinics, not to
reproductive material sold for self-insemination. 68 Further, there are
reports of individuals smuggling reproductive materials over borders,
entirely circumventing their jurisdiction's regulations and the standards
enforced by the fertility industry. 69
Without stepping foot outside one's city, an individual can obtain
reproductive

materials

from

nearly

anywhere

in

the

world.

An

individual could also ship reproductive materials to a location with more
advantageous

regulations. 70 In addition

to the growing

technical

capabilities of ART, this globalization introduces a number of issues,
including a lack of global standards for testing reproductive material
prior to use, monitoring the number of allowed offspring from a single
donor, and maintaining anonymity obligations, to name only a few.
Donor Anonymity Regulations
Before discussing the details of various reproductive regulations
within the United States and the United Kingdom, it is useful to
understand the basic approaches taken to regulate donor anonymity. In
a recent study, it was found that most countries banning donor
anonymity require all donors to list their identifying information within

a registry that becomes available to donor-conceived children at
eighteen years old.71 Donor-conceived persons and their parents could
potentially never receive identifying information of their donor in
countries that continue to allow donor anonymity. Surveying the
practices in the United States and the United Kingdom illustrates the
differences among countries' regulations for the fertility industry,
including for donor anonymity. Both countries represent contrasting
models of how donor anonymity is handled, offering key insights. The

67. Id.
68. See id. (implying men can still sell their sperm privately on online forums to bypass
testing standards).
69. See generally Mohammed Hamdan, "Every Sperm Is Sacred": Palestinian Prisoners,
Smuggled Semen, and Derrida's Prophecy, 51 INT'L J. MIDDLE EAST STUD., 525 (2019)
(describing the contemporary phenomenon of smuggling sperm from within Israeli jails,
which is treated as a biopolitical act of resistance).
70. See Harper et al., supra note 66, at 1136.
71. Cohen et al., supra note 25, at 470.
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differences in reproductive regulation largely stem from each country's
values. 72

United States
The United States often treats healthcare as a market commodity. 7
While the United States generally regulates quality control-such as
the licensing of providers and clinics as well as the oversight of drugs,
devices, and research-state and federal governments oversee
regulation of reproductive medicine. 74 Similar to other medical
practices, reproductive medicine also involves "professional selfregulation that includes facility accreditation and practitioner
certification." 75 ART development is monitored by the American Society
for Reproductive Medicine (ASRM) and its affiliate, the Society for
Assisted Reproductive Technology (SART).76 The members of these
societies include reproductive
specialists,
"patient advocates,
congressional and federal agency representatives, legal experts, and
consumers." 77

State regulation of the fertility industry is crucial within the United
States because states are responsible for exercising their police powers
to grant medical licenses to "practitioners who meet minimum
standards of education and skill." 78 States exercise control over the
industry by "defin[ing] grounds for misconduct, such as negligence,
deceit, fraud, or exploitation of the physician-patient relationship." 79
State legislatures pass medical practice acts and the acts are enforced
by states' medical licensing boards. 80 A medical license is often broad
and not limited to certain types of medicine. 81 Instead, states' medical

72. See Alicia Ouellette et al., Lessons Across the Pond: Assisted Reproductive
Technology in the United Kingdom and the United States, 31 AM. J.L. & MED. 419, 435-46
(2005) (discussing the difference in ART regulation between the United States and the
United Kingdom).
73. Id. at 444.
74. AM. SOC'Y FOR REPROD. MED., OVERSIGHT OF ASSISTED REPRODUCTIVE
TECHNOLOGY 3 (2010).
75. Id. at 4.
76. Id.
77. See id.
78. Id. at 5.
79. Id.
80. Id. The regulations "define a scope of practice for licensees, require ongoing
educational training through approved continuing medical education, and authorize
discipline for those who break the law or fail to uphold certain professional standards." Id.
81. Id.
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boards define a scope of practice and practitioners can become board
certified. 82
The United States federal government also has a role in the
oversight of ART, specifically through the Centers for Disease Control
and Prevention (CDC), Food and Drug Administration (FDA), and
Centers for Medicare and Medicaid Services. 83 These organizations each
have their own regulatory responsibilities. 84
In 1992, the United States passed federal legislation relating to
ART: Public Law 102-493, the Fertility Clinic Success Rate and
Certification Act. 85 This act requires annual reporting of ART cycle data
to the CDC.86 The CDC reports the data to the public, providing
consumers access to ART data and success rates nationwide. 87 The
annual reports submitted to the CDC include information ranging from
data about individual clinics to national data on infertility treatment
success rates. 88 The act "does not regulate the safety or uses of sperm or
eggs or embryos but, instead, is designed simply to provide access to
information about the success rates of fertility clinics." 89 Also, the act
aims to prevent clinics from advertising false pregnancy success rates. 90
In an effort to avoid poor outcomes, the act establishes a model
program for the certification of embryology laboratories, which outlines
the "administration of a continuing certification program by the states,
quality assurance and control standards, an inspection system, and
conditions under which certification can be suspended or revoked." 91
Critically, the adoption of such a laboratory certification program is left
entirely up to the states. 92

82.
83.
84.
85.
86.
87.
88.

Id.
Id.
Id.
Id.
Id.

Id. at 6.
Id.

89. NAOMI R. CAHN, TEST TUBE FAMILIES: WHY THE FERTILITY MARKET NEEDS LEGAL

REGULATION 54 (2009) (explaining the setbacks with ART regulation).
90. Id. at 53-54. See also AM. SOC'Y FOR REPROD. MED., supra note 74, at 6 ('The data
collected include the patients' infertility diagnoses, clinical information pertaining to the
ART procedure, and statistics on resulting pregnancies and births.").
91. AM. SOC'Y FOR REPROD. MED., supra note 74, at 6.
92. The first set of data on success rates was not published until five years after
Congress enacted the Act. If fertility clinics do not provide data about their programs,
there are no sanctions beyond being listed as "nonreporting." Further, this Act does not
apply to sperm banks or to clinics that only involve artificial insemination-it only covers
programs that provide treatments involving embryos or eggs. See generally CAHN, supra
note 89 (explaining the setbacks with ART regulation).
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In the United States, the FDA protects "public health by assuring
the safety, efficacy, and security of drugs, biological products, and
medical devices." 93 With this responsibility "[t]he FDA also has
jurisdiction over the screening and testing of reproductive tissues, such
as .

.

. eggs and sperm." 94 The FDA's "good tissue practices" as codified

list the requirements for egg and sperm donors, identification controls,
the prevention of the spread of infectious diseases, and inspection of
facilities that handle reproductive services. 95
The Centers for Medicare and Medicaid Services (CMS) regulate the
diagnostic testing of humans and reproductive specimen under the
Clinical Laboratory Improvement Act (CLIA).96 The CLIA program

ensures "quality laboratory testing by establishing standards for
accuracy, reliability, and timeliness of patient test results." 97 Only lab
tests that make a diagnosis, however, are covered by the CLIA.98 Thus,
blood and semen analysis that diagnose infertility would be covered by
the CLIA, but the other procedures in embryology labs that are not
diagnostic are not covered by the CLIA.99
In addition to federal and state level regulations, the United States
also relies heavily on professional self-regulation within the fertility
industry. 100 Examples of professional self-regulation include laboratory
board certification,
and professional
accreditation,
physician
guidance. 101 For laboratory accreditation, the College of American
Pathologists and ASRM developed standards "specific as to the
education, certification, and expertise of laboratory personnel," and
require that "[t]he laboratory must have a performance improvement
plan and a quality control program to anticipate and prevent errors."

102

Further, there is a laboratory testing program that assures testing
reliability. 103 To maintain accreditation, laboratories are subject to CMS
inspections and "must perform periodic self-evaluations and document
any necessary corrective actions between site visits." 104

93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.

AM. SOC'Y FOR REPROD. MED., supra note 74, at 6.

Id.
Id.; 21 C.F.R. § 1271 (2019),
AM. SOC'Y FOR REPROD. MED., supranote 74, at 6.
Id. at 7.

Id.
Id.
Id.

Id.
Id. at
Id.
Id.

8.
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Physician board certification in the area of fertility and obstetrics is
necessary because of the specialty of this area of medicine. 105 In the
United States, "[t]he American Board of Medical Specialties establishes
criteria for its member organizations . . . ." 106 To become a board
certified obstetrician / gynecologist, practitioners must undergo "four
years of training, plus two years in clinical practice . . . followed by
training in reproductive endocrinology and infertility. . . " 107 The board

sets standards for the training and performance of physicians. 108 After
becoming board certified, physicians continue to keep their skills and
knowledge current through participation in a maintenance of
certification program. 109
Lastly, ASRM and SART act as sources of professional guidance.
ASRM "is the specialty society for physicians that focus on infertility." 11o
It has a Practice Committee that creates "regular reports, including
guidelines on minimal standards for providing ART, informed consent,
and on the number of embryos to be transferred in IVF procedures." 11
Additionally, the SART is an affiliate of ASRM and has strict
membership requirements, including compliance with the reporting
standards for clinics, the accreditation of embryology laboratories,
adherence to the ethics and practice committee guidelines, and
employment of appropriately trained staff. 112

Before discussing the United Kingdom's fertility regulations, it is
important to note a few gray areas in the United States fertility
industry. Recent scholarship has noted that there is no law in the
United States that requires ART programs to have licensing or
accreditation. 113 Though section 3(a) of the Fertility Clinic Success Rate
and Certification Act specifies that the CDC should develop a laboratory
certification program, the CDC has not been able to require clinics to
meet these standards in practice, largely because of states'
responsibilities to adopt their own regulations for clinics. 114 Further,
failure to adhere to ASRM and SART criteria does not impact the ability

105. See id.
106. Id.
107. Id.
108. Id.
109. Id.
110. Id. at 9.
111. Id. ("The guidelines are distributed to all members of ASRM, are published in the
Society's journal, Fertility and Sterility, and are available to the public on ASRM's
website.").
112. Id.
113. Ouellette et al., supra note 72, at 429.
114. Id. at 430.
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of clinics to continue operating. 115 Membership in ASRM and SART is
completely voluntary, which makes their detailed guidelines also
essentially voluntary. 116
Research into the United States' approach to fertility regulation
highlights the lack of incentive among donors, recipients, banks, clinics,
and physicians "to push for public regulation" because it "might result
in additional restrictions on their activities,"117 or increased cost in
procedures. Further, restrictions accompanying new fertility regulations

might negatively impact research studies and trials of reproductive
technology. With the quickly advancing reproductive industry and the
resulting increased demand for donor reproductive materials, research
and trials are critical to ensure safety and good practice.
Additionally, the economic forces of the industry support the lack of
regulation.11 8 The reproductive industry earns approximately $3-4
billion annually. 119 Individuals using ART technologies, especially donor
reproductive material, are often characterized as having elastic budgets
to create or expand their families. 120 Donors want to sell, recipients
want to buy, and clinics want to profit-ART regulation may not easily
fit into this equation. 121

United Kingdom
The United Kingdom's regulation of the reproductive industry is
seemingly more expansive and more enforceable than the regulations in
the United States. The government regulates virtually every kind of
healthcare in the United Kingdom, including the fertility industry
under the Human Fertilization and Embryology Act of 1990 (HFE).122
This act outlines the functions and procedures of the Human
Fertilization and Embryology Authority (HFEA).123 The HFEA has
115. AM. SOC'Y FOR REPROD. MED., supra note 74, at 9.
116. See id. at 10.
117. CAHN, supra note 89, at 20.
118. See generally DAAR, supra note 37 (explaining the conflict of interest physicians
often face with maximizing opportunities of pregnancy and receiving profits from infertile
couples); Mary Lyndon Shanley, Collaboration and Commodification in Assisted
Procreation: Reflections on an Open Market and Anonymous Donation in Human Sperm
and Eggs, 36 L. & SOC'Y REv. 257, 259 (2002) (stating that the transfer of gametes has
taken a market analogy, which becomes difficult to argue against once established).
119. DAAR, supra note 37, at 183.
120. Id.
121. See generally David Adamson, Regulation of Assisted Reproductive Technologies in
the United States, 39 FAM. L.Q. 727, 728 (2005) (arguing that the United States does have
an effective regulating system of ART practices).
122. Human Fertilization and Embryology Act, 1990, c. 37 (Eng.).
123. Ouellette et al., supra note 72, at 420-21.
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complete authority over fertility clinics and fertility research centers; all
clinics using reproductive material must receive a license and "follow
guidelines for data reporting, advertising, confidentiality, and clinic
practices." 124 These guidelines are enforced through powers granted to
the HFEA by the British Parliament. 125 Breaches of the Code of Practice

put clinics and research centers at risk of losing their licenses, thus not
being able to operate. 126 Regulation through the HFEA is broken into
three categories: licensing, inspections, and setting standards, 12 7 which
ensure fertility clinics and research centers comply with current law,
rules, and standards to promote high-quality care and research.
All fertility clinics and human embryo research centers in the
United Kingdom must comply with the 1990 and 2008 versions of the
HFE and a number of related pieces of legislation. 128 To provide
guidance to clinics and research centers, the HFEA published and
routinely updates a Code of Practice that informs clinics and research
centers how to meet legal requirements. 129
In the United Kingdom, all fertility clinics and human embryo
research centers are required by law to apply for a license to perform
any related work. 130 The HFEA grants licenses for a maximum of four
years, with all new clinics automatically receiving a license to operate
for two years. 131 The HFEA conducts periodic inspections to make sure
services meet the standards in the Code of Practice. 132 The findings are

presented to a license committee, which decides whether to grant a
license, refuse a license, or put conditions on a license to ensure
improvements are made. 133 If it grants a license, the committee also
decides how long that license will last. 134
Before the HFEA grants a new license, or renews an existing one, it

conducts an inspection of the facility.

135

For existing clinics and centers,

the HFEA conducts inspections every two years to ensure clinics and

research centers are abiding by the Code of Practice, 136 though the
124. Id. at 421.
125. Id.
126. Compliance and Enforcement Policy, HUM. FERTILISATION & EMBRYOLOGY AUTH.
(Mar. 09, 2016), https://www.hfea.gov.uk/media/1494/compliance-and-enforcement-policy.pdf
127. How We Regulate, HUM. FERTILISATION & EMBRYOLOGY AUTH., https://www.hfea.

gov.uk/about-us/how-we-regulate/ (last visited Oct. 15, 2020).
128. Id.
129. See id.
130. Id.
131. Id.
132. Id.
133. Id.
134. Id.
135. Id.
136. Id.

I JUST TOOK A DNA TEST

311

HFEA also inspects clinics and centers more frequently if needed-for
example, if it receives a report about something that is a cause for
concern.

137

Further, depending on the type of inspection, the HFEA can

decide whether to notify the clinic of an upcoming inspection.138 The
inspection includes verifying whether the clinic implemented the
HFEA's

requested

improvements

and

monitoring

how

those

improvements have progressed based on criteria established by key
standards set by the board.139 The inspectors put all findings into a
public report, "identifying any areas which they are concerned about
[clinics' noncompliance] and recommending how they can improve." 140
As previously mentioned, the HFEA sets standards by publishing
and routinely updating a document called the Code of Practice.141 The
Code includes directions to ensure all clinics and centers carry out the
latest procedures and practices properly.142 The HFEA also produces
consent forms that are used in all clinics to ensure national uniformity,
as clinics in the United Kingdom must receive written consent to
perform services such as fertility treatments; storage of sperm, eggs,

and embryos; donation; surrogacy; and disclosure of information. 143
In an effort to provide donor-conceived individuals with more
information about their origins, the United Kingdom enacted the
Human Fertilization and Embryology Authority (Disclosure of Donor
Information) Regulations 2004, effective beginning April 2005, that
banned donor anonymity. 144 This law requires donors to enter personal
information into a registry when donating reproductive material,
including both non-identifying and identifying information. 145 A donor-

137. Id.
138. Id.
139. Id.
140. Id.
141. Code

of

Practice,

HUM.

FERTILISATION

&

EMBRYOLOGY

AUTH.

(2018),

https://www.hfea.gov.uk/media/2565/hfea-draft-code-of-practice-9th-edition-consultationversion.pdf.
142. How We Regulate, supra note 127.
143. Id. The HFEA has also created forms using gender-neutral language to
accommodate trans and nonbinary patients. To view these forms, see Consent Forms,
HUM.

FERTILISATION

&

EMBRYOLOGY

AUTH.,

https://portal.hfea.gov.uk/knowledge-

base/consent-forms (last visited Dec. 9, 2019).
144. The Human Fertilisation and Embryology Authority (Disclosure of Donor
Information) Regulations 2004, SI 2004/1511, art. 2 (Eng.).
145. Andrew Hellman & Glenn Cohen, ProhibitingSperm Donor Anonymity in the US
and Possible Effects on Recruitment and Compensation, BIONEWS (Apr. 3, 2017),
https://www.bionews.org.uk/page_95954.
Non-identifying information includes factors
such as physical characteristics and medical background while identifying information
includes factors such as full name and date of birth. Why Donate, LONDON SPERM BANK,
https://www.londonspermbank.com/donor/why-donate/ (last visited Mar. 12, 2021).
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conceived child could obtain "a donor's non-identifying information at
age sixteen and . . . their identifying information at age eighteen." 146
This registry includes "patient and partner names, patient reference
numbers, treatment dates, and details of sperm and egg donors." 147
Because the ban on anonymity is not retroactive,

the HFEA also

provides information and resources to donors, donor-conceived
individuals, and parents of donor-conceived children who fall into the
time period predating the new ban on anonymity.148 Parents of donorconceived children in the United Kingdom do not have the right to
access any of this information; the right to access this register is
granted solely to donor-conceived children who have reached the
appropriate age as prescribed by the HFEA.1 4 9

Further illustrating the elaborate fertility regulations in the United
Kingdom, the HFEA has collected information about all fertility
treatments involving a donor since August 1, 1991.150 This data is now

the largest data collection of its type in the world. 151 These records track
every person who receives ART treatments in licensed clinics, donors of
embryos,
and
individuals born
through
ART in
licensed
clinics. 152Additionally, the gathered data is maintained in a national
registry, which attempts to avoid situations where two donor-conceived
individuals might be involved in an intimate relationship. 153

The United Kingdom has also taken a substantial step in fertility
regulation by acknowledging the capabilities of current technologies

&

146. Id.
147. Ouellette et al., supra note 72, at 424.
148. See Finding Out About Your Donor and Genetic Siblings, HUM. FERTILISATION
EMBRYOLOGY AUTH., https://www.hfea.gov.uk/donation/donor-conceived-people-and-theirparents/finding-out-about-your-donor-and-genetic-siblings (last visited Dec. 9, 2019). The
type of information held by the HFEA depends on when the individual was conceived, as
the information donors are required to provide has changed over the years. Id. If a donorconceived person living in the United Kingdom was born prior to August 1, 1991 (when
data collection began), she can contact the Donor Conceived Register, run by the Hewitt
Fertility Centre. Id. If a donor-conceived person was conceived between August 1, 1991,
and March 31, 2005, she can request the HFEA to provide her donor's physical
description, the year and country of their birth, their ethnicity, whether they had any
children at the time of donation, and any additional information the donor chose to supply.
Id.
149. Rules Around Releasing Donor Information, HUM. FERTILISATION & EMBRYOLOGY
AUTH., https://www.hfea.gov.uk/donation/donors/rules-around-releasing-donor-information
(last visited Dec. 9, 2019).
150. Donor-Conceived People and Their Parents, HUM. FERTILISATION & EMBRYOLOGY
AUTH. (Apr. 28, 2020), https://www.hfea.gov.uk/i-am/donor-conceived-people-and-theirparents.
151. Ouellette et al., supra note 72, at 423.
152. Id.
153. Id. at 424.
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used by the public. The HFEA released a statement on its site, warning
individuals of the consequences of direct-to-consumer DNA testing
services:

[I]t's important to know that it's also possible for home
DNA testing and matching services, available online, to
result in you being identified, regardless of when you
donated. People use these sites to find out about
ancestry, health and/or identify their genetic relatives.
Many of the sites also allow users to "match" and make
contact with other users on their database with whom
they are genetically related, often using their real
names. Even if you don't use one of these sites yourself,
if one of your close genetic relatives and someone
conceived from your donation are both signed up to it,
you could potentially become identifiable. Your identity
could be inferred, if information about genetic "matches"
is combined with other publicly-available information
about you. 154
This statement, coming directly from the government, rather than
fertility clinics that choose to accept this new reality, ensures
consistency of expectations relating to donor anonymity.

The HFEA is seemingly successful in the United Kingdom because
of the country's "tradition of national control over health care." 155
Healthcare in the United Kingdom is seen as a public commodity. 156 The
regulations tend to balance the private and public interests, though
some view them as having a paternalistic impact on the industry. 157 The
United Kingdom's system of fertility regulations appears to be more
expansive, monitored, and followed.
II.

DIRECT-TO-CONSUMER DNA TESTING

&

23ANDME

A growing number of companies now offer direct-to-consumer DNA
tests that provide consumers with information ranging from their
ancestry to the existence of genetic risks for certain medical diseases or

154. Rules Around Releasing Donor Information, supra note 149.
155. Ouellette et al., supra note 72, at 444.
156. Id.
157. Id. at 445.
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conditions. 158 Direct-to-consumer DNA tests generally only require a
small fee and a specimen, usually saliva. 159 Then, the company analyzes
the DNA and reports information to the consumer. 160 By the start of
2019, more than twenty-six million consumers had added their DNA to
four leading direct-to-consumer DNA testing companies, 161 one giant
being 23andMe, which currently ships DNA kits to fifty different
countries. 162

These tests have gained popularity with users around the world. 163
Rationales for direct-to-consumer DNA testing include genealogical
curiosity and avoidance of costly insurance plans and appointments
with physicians. 164 Internationally, 23andMe is widely known for the
service of connecting biologically related individuals through DNA
analysis. 165 But recently, 23andMe has expanded from an ancestry test
to a test that screens for genetic-risk information. 166 The goal of the
health portion of the test is to "give individuals a deeper understanding
of their health risks" and to encourage consumers to share their results
with healthcare providers for a more complete diagnosis and
treatment. 167

As early as December of 2014, the United Kingdom's Medicines and
Healthcare Products Regulatory Agency had given approval for

158. Sarah Schmidt, 9 Leading Companies in Direct-to-Consumer Genetic Testing,
MARKETRESEARCH.COM BLOG (Apr. 6, 2016) https://blog.marketresearch.com/9-leadingcompanies-in-direct-to-consumer-genetic-testing.
159. Compare Our DNA Tests, 23ANDME, http://www.23andme.com/compare-dna-tests/
(last visited Aug. 6, 2020). One can purchase a 23andMe Ancestry test for $99, or a Health
& Ancestry test for $199. Id.
160. A person's genome "is made up of thousands of genes that carry the hereditary
information about your traits . . . This information is based on the arrangement of distinct
molecules that make up genes. Some of these arrangements, or variants, can be used to
diagnose a rare disease" and to "provide information about a person's risk of developing
disease." Direct-to-Consumer Tests, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/
medical-devices/vitro-diagnostics/direct-consumer-tests (last visited Mar. 12, 2021).
161. Antonio Regalado, More Than 26 Million People Have Taken an At-Home Ancestry
Test, MIT TECH. REv. (Feb. 11, 2019), https://www.technologyreview.com/s/612880/morethan-26-million-people-have-taken-an-at-home-ancestry-test/.
162. What Countries Do You Ship To?, 23ANDME, https://int.customercare.
23andme.com/hc/en-us/articles/214806628-What-countries-do-you-ship-to(last visited
Dec. 16, 2019).
163. Regalado, supra note 161.
164. Schmidt, supranote 158.
165. Id.
166. Genetic Health Risks, 23ANDME, https://www.23andme.com/test-info/ (last visited
Oct. 5, 2020).
167. Jeff Martin, Keith Mong & James Sanchez, Genetic Testing May Be Tax Deductible,
GRANT THORNTON (Aug. 13, 2019), https://www.grantthornton.com/library/newsletters/
tax/2019/hot-topics/aug-13/genetic-testing-tax-deductible.aspx.

I JUST TOOK A DNA TEST

315

23andMe to market and sell its direct-to-consumer DNA health tests in
the country. 168 An agency spokesperson stated that the agency had
tested the company's kits and ensured they met minimum standards. 169
Additionally, the UK Department of Health and Social Care supported
using gene tests to guide patient care.

170

Several years later, in 2018, the United States FDA authorized
23andMe to market one of its testing kits. 171 The FDA regulates this kit
as a medical device 172 as it reports medical information directly to
consumers.173 23andMe is currently the only direct-to-consumer DNA
testing entity that can advertise and screen for important medical
information in the United States. 174
The test screens for certain genetic health risks including
Alzheimer's, Parkinson's, and certain variants of genes associated with
a higher risk of breast and ovarian cancer (also known as BCRA
genes). 175 Further, as of October 2018, the FDA concluded that the test
may also be used to inform a patient of her ability to metabolize certain
medications. 176 The FDA's review of 23andMe's test found that the
company provided accurate data to consumers and that consumers could
correctly understand the results of the test. 177 This will undoubtedly
change the medical industry, as results from a direct-to-consumer DNA
test can now be used to help inform discussions with healthcare
providers.
In addition to the United States regulating 23andMe's test as a
medical device, a recent IRS ruling 178 issued to 23andMe "clarified that
168. Michelle Roberts & Paul Rincon, ControversialDNA Test Comes to UK, BBC NEWS
(Dec. 2, 2014), https://www.bbc.com/news/science-environment-30285581.
169. Id.
170. Id.
171. Press Release, U.S. Food & Drug Administration, FDA Authorizes First Direct-toConsumer Test for Detecting Genertic Variants that May be Associated with Medication
Metabolism (Oct. 31, 2018) (on file with author) [hereinafter FDA Press Release].
172. Id.
173. Id.
174. Anna Almendrala, Home Genetic Tests May Be Riddled With Errors, And
Companies Aren't Keeping Track, Huffpost (Apr. 3, 2018, 5:45 AM), https://www.
huffpost.com/entry/home-genetic-test-false-positives_n_5ac27188e4b04646b645 1c42.
175. Lists of Direct-To-Consumer Tests, FDA (Dec. 20, 2019), https://www.fda.gov/
medical-devices/vitro-diagnostics/direct-consumer-tests#list. The following 23andMe tests
have received marketing authorization by the FDA: 23andMe PGS Carrier Screening Test
for Bloom Syndrome, 23andMe PGS Genetic Health Risk Test, 23andMe PGS Genetic
Health Risk Report for BRCA1/BRCA2, and 23andMe PGS Pharmacogenetic Reports. Id.
176. FDA Press Release, supra note 171.
177. Id.
178. A private letter ruling (PLR) is a written statement issued by the IRS to "establish
with certainty the federal tax consequences of a particular transaction before the
transaction is consummated or before the taxpayers return is filed . . .. A PLR may not be
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certain genetic testing services may constitute medical care for purposes

of Section 213(d) of the Internal Revenue Code." 179 This ruling indicates
that expenses used for qualifying genetic testing services can be
submitted for reimbursement to healthcare flexible spending accounts
and health savings accounts or, alternatively, deducted as expenses paid
for medical care. 180 Though the ancestry portion of 23andMe will not
receive tax deductions, consumers can claim a deduction for the health
portion at a maximum $177.74 of the $199.00 cost of a health-andancestry kit. 181 Such a substantial deduction increases the access to
23andMe's DNA tests, meeting the high and rising testing demands.
23andMe has stated that its services "are not designed for, intended
to attract, or directed toward" minors. 182 A parent or guardian, however,
"may collect a saliva sample from, create an account for, and provide
information related to his or her child who is under the age of
[eighteen]."18 3 Interestingly, 23andMe released a holiday commercial in
2018 in which the Grinch receives the company's DNA kit as a gift and
signs on to 23andMe's site to discover his results. 184 This clever

&

relied on as precedent by other taxpayers or IRS personnel." Understanding IRS
Guidance: A Brief Primer, IRS (last updated Nov. 6, 2019), https://www.irs.gov/newsroom/
understanding-irs-guidance-a-brief-primer.
179. Susan M. Nash & Susan P. Schaefer, Recent IRS Ruling Clarifies Tax Treatment of
Genetic Testing
Services, WINSTON
& STRAWN
LLP
(Aug.
16,
2019),
https://www.winston.com/en/benefits-blast/recent-irs-ruling-clarifies-tax-treatment-ofgenetic-testing-services.html#!/closedtstate. To note, IRS PLRs may only be relied upon by
the taxpayer who requested the ruling, but they are informative about the IRS's
viewpoint. UnderstandingIRS Guidance: A Brief Primer, supra note 178.
180. Nash & Schaefer, supra note 179 ('Because the genetic testing services included
items that are considered medical care (such as genotyping and laboratory services), and
items that are not considered medical care (such as general informational reports for
purposes of determining ancestry), the IRS required an allocation of the price paid for the
DNA collection kit and health services . . . to determine the portion that constitutes
Section 213(d) medical expenses.").
181. Richard Rubin & Amy Dockser Marcus, IRS Greenlights Tax Breaks for Buyers of
23andMe Genetic Tests, WALL ST. J. (July 22, 2019), https://www.wsj.com/articles/irsgreenlights-tax-breaks-for-buyers-of-23andme-genetic-tests-11563800520. See also Nash
Schaefer, supra note 179 ('Because the genetic testing services included items that are
considered medical care (such as genotyping and laboratory services), and items that are
not considered medical care (such as general informational reports for purposes of
determining ancestry), the IRS required an allocation of the price paid for the DNA
collection kit and health services . . . to determine the portion that constitutes Section
213(d) medical expenses.").
182. Privacy Highlights, 23ANDME, https://www.23andme.com/about/privacy/ (last visited
Mar. 12, 2021).
183. Id.
184. Emily Mullin, Should You Send Your Kid's DNA to 23andMe?, WASH. POST (Dec.
19, 2018, 9:00 AM), https://www.washingtonpost.com/lifestyle/2018/12/19/should-you-sendyour-kids-dna-andme/.
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marketing seems to be aimed at kids and families generally, despite the
company's statement that the tests are not designed for children. 185
23andMe is not alone, either. One study suggested that nearly one-third
of direct-to-consumer DNA testing companies have provided results to
minors upon parental request. 186 Whether 23andMe intends to test
minors' DNA, the company has not disallowed the practice and
continues to analyze kits belonging to minors. 187
In sum, the United Kingdom's early approval of using 23andMe for
specific genetic-risk

testing demonstrates

the country's

support of

providing individuals access to important health information. Further,
the United States' FDA approval and IRS tax deduction for specific
23andMe tests suggests that the federal government considers this
service valuable and important for its nation's consumers. Learning
about genetic risks associated with one's characteristics enables
individuals to prepare for the possibility of abnormality or disease.
Knowledge of genetic risks also promotes increased medical knowledge
about oneself, which is useful for healthcare providers.
III. PARENTAL MEDICAL-DECISION-MAKING IN THE UNITED STATES AND
UNITED KINGDOM

Parental autonomy over minor children is not an absolute right, 188
neither in the United States nor in the United Kingdom. A court in the
United States stated that "the essential element of preserving the
integrity of the family is maintaining the autonomy of the parent-child
relationship." 189 Therefore, the government can intrude on a parent's
right to care for a child only for the most compelling reasons. 190
Additionally, United States common law recognizes parental authority
to make fundamental decisions for minor children, specifically in

185. Privacy Highlights, supra note 182.
186. Heidi Carmen Howard et al., Are the Kids Really All Right? Direct-to-Consumer
Genetic Testing in Children: Are Company Policies Clashing with Professional Norms? 19
EUR. J. HUM. GENETICS 1122, 1122-23 (2011) (describing different direct-to-consumer
DNA testing companies' protocol when testing minors).
187. See Privacy Highlights, supra note 182 ('The parent or guardian assumes full
responsibility for ensuring that the information that he/she provides to 23andMe about his
or her child is kept secure and that the information submitted is accurate.").
188. Newmark v. Williams, 588 A.2d 1108, 1116 (Del. 1991) (explaining that a child
diagnosed with Burkett's lymphoma and was given a forty percent chance of survival if he
obtained chemotherapy treatments. The court held that the parents were within their
rights to forgo treatment).
189. Id. at 1115.
190. See id. at 1117.
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instances involving medical treatment for a minor. 191 Thus, a state may
intervene in the parent-child relationship only where the health and
safety of the child or the public at large is in jeopardy.192 A brief
analysis of parental medical-decision-making rights in the United
States and the United Kingdom follows.
United States
Most jurisprudence in the United States has recognized the family
as a protected unit, which gives parents broad authority over minor
children. 193 Courts interpreting the Constitution have "rejected any
notion that a child is 'the mere creature of the State' and, on the
contrary, asserted that parents generally 'have the right coupled with
the high duty, to recognize and prepare [the children] for additional
obligations."' 194 The bond between a parent and child typically leads
parents to act in the best interests of the child.195 Because of this bond,
courts have given deference to parental decisions regarding the care of
minor children. 196

In light of this deference, courts undoubtedly recognize a parental
duty to recognize symptoms of illness and to seek medical treatment, if
available. 197 This is because a minor generally lacks the capacity to
consent to medical treatment herself. 198 It follows that parents also have
191. Id. at 1115-16.
192. Id. at 1116.
193. See generally, e.g., Wisconsin v. Yoder, 406 U.S. 205 (1972) (holding that a state
law mandating school attendance by children under age sixteen is unconstitutional as
applied to Amish children); Prince v. Massachusetts, 321 U.S. 158 (1944) (holding that it
is constitutional for the state to step in during situations of child labor); Pierce v. Soc'y of
Sisters, 268 U.S. 510 (1925) (requiring children to be educated only in public schools
violates the Fourteenth Amendment of the U.S. Constitution); Meyer v. Nebraska, 262
U.S. 390 (1923) (invalidating as unconstitutional a Nebraska law banning the teaching of
foreign languages to schoolchildren).
194. Parham, 442 U.S. at 602 (internal citations omitted).
195. Id. (citing 1 W. Blackstone, Commentaries 447; 2 J. Kent, Commentaries on
American Law 190).
196. See generally, e.g., Yoder, 406 U.S. 205 (holding that a state law mandating school
attendance by children under 16 is unconstitutional as applied to Amish children) Prince,
321 U.S. 158 (holding that it is constitutional for the state to step in during situations of
child labor); Pierce, 268 U.S. 510 (requiring children to be educated only in public schools
violates the Fourteenth Amendment of the U.S. Constitution); Meyer, 262 U.S. 390
(invalidating a Nebraska law banning the teaching of foreign languages to schoolchildren).
197. Parham, 442 U.S. at 602.
198. See generally EVALUATION AND TREATMENT OF MINORS, AM. COLL. EMERGENCY

PHYSICIANS (2017) (examining "current federal and state legal implications of providing
emergency care to minors, as well as guidance in obtaining consent, maintaining
confidentiality, and addressing refusal of care").
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the ability to seek preventative care for their children, including
genetically testing a child to discover allergies to certain medications,
food intolerances, and dispositions to fatal diseases. This seems
especially important for children who were conceived with donor
reproductive materials because at least half of their genetic history
remains unknown to them. In this way, it is arguable that parents could
use direct-to-consumer DNA testing as an informative tool to better
educate them about their donor-conceived child's genetic information.
United Kingdom
The jurisprudence

in the United Kingdom

involving parental

medical-decision-making capacity is similar to that of the United States.
Aside from extreme circumstances, the United Kingdom generally
recognizes that
the parents are the best people to make decisions about
a child and the State-whether it be the court, or any
other public authority-has no business interfering with
the exercise of parental responsibility unless the child is
suffering or is likely to suffer significant harm as a
result of the care given to the child not being what it
would be reasonable to expect a parent to give. 199
In this way, there is a recognized parental right to control a minor's
medical treatment in the United Kingdom. 200 It follows that a parent of
a donor-conceived child could have a legitimate interest in gaining
insight into the genetic information of the minor child through a directto-consumer DNA test, like 23andMe. Though the test is not regulated
as a medical device in the United Kingdom, the country has emphasized
the test's importance with respect to the allowance of genetic testing
throughout the country.201 The results from the test provide genetic and
medical information about an individual, here a donor-conceived child,
which seems to support the doctrine of acting in the best interest of a
child.
In a typical medical setting, minor children are not routinely
screened for many of the specific health risks for which direct-to199. Jo Bridgeman, Innovative Therapy and the Law: The Novel Issues Raised by the
Case of Charlie Gard, 34 PROF. NEGL. 5, 5-20 (2018), citing In the Matter of Ashya King
[2014] EWHC (Fam.) 2964, [31].
200. Re C (children) [2016] EWCA (Civ) 374, [43] (Lady Justice King) (appeal taken
from the Swansea Family Court) (quoting Sharpe J in the Family Court).
201. Roberts & Rincon, supra note 168.
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consumer DNA companies test. 202 Additionally, some fertility clinics do
not screen donors for certain genetic abnormalities when collecting
reproductive material and using reproductive material in assisted
reproductive procedures. 203 As a result, many parents may turn to

direct-to-consumer DNA tests to seek answers to questions that are not
easily answerable due to anonymity regulations.
IV. INTERPLAY BETWEEN DONOR ANONYMITY AND DIRECT-TO-CONSUMER
DNA TESTING

Globally,

there

is

still

variability

with

donor

anonymity

regulations. 2 04 Children born with donor reproductive material will

often face different setbacks to learning their genetic information
depending on the jurisdiction in which they are born. One similarity
among nearly all countries, though, is the position of the parents.
Unless a donor consents to identification, minor, donor-conceived
children may: (1) wait for nearly two decades to learn of important
genetic information on their own (in places with regulations banning
complete anonymity), or (2) never have the ability to learn about the
genetic information, including harmful genetic dispositions. Both
positions essentially leave parents without the power to make decisions
in the best interests of their donor-conceived children.
The issue some fertility clinics have faced with parents using directto-consumer DNA testing on minor, donor-conceived children is the
adherence to the donor anonymity contract. 205 Generally, it is unlikely
that clinics intend to act as a barrier to parents' rights to make medical
decisions for their donor-conceived children. It is more likely that clinics
fear that parents of donor-conceived, minor children will use direct-toconsumer DNA testing as a mechanism to learn the identity of the
donor and attempt to connect with the donor. This could substantially
decrease the number of individuals who would be willing to donate
reproductive materials if they wish to remain anonymous. 206 This would

202. Megan

Freedman, Health Screening Milestones for School-Aged Children,
https://www.healthgrades.com/right-care/childrens-health/health-screeningmilestones-for-school-aged-children (last updated Jan. 10, 2020).
203. See Information Packet for Use of Donor Sperm, SHADY GROVE FERTILITY (Apr.
2017), https://www.shadygrovefertility.com/application/files/7614/9426/4295/11CPD2.01.01_
DonorSpermInfoPacket.revApr17.pdf.
204. Cohen et al., supra note 25, at 469.
205. Teuscher v. CCB-NWB, LLC, 437 F. Supp. 3d 849 (E.D. Wash. 2020) (No. 19-CV00204).
206. See generally Meghana Keshavan, 'There's No Such Thing as Anonymity': With
Consumer DNA Tests, Sperm Banks Reconsider Long-Held Promises to Donors, STAT
HEALTHGRADES,
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also subject the clinics to virtually limitless liability for donors to whom
they promised anonymity. 207

At first glance, it seems that parents of donor-conceived children in
the United States and the United Kingdom have the potential to bypass
various anonymity regulations by using direct-to-consumer DNA testing

provided by companies such as 23andMe. In the United States, with
23andMe's health test receiving FDA marketing authorization, 208
parents may have an easier time, as courts generally defer to a parent's
decision about the care of a minor child-especially medical decisions. 209
In the United Kingdom, this argument is similar because of the
Department of Health's support of using the test. 2 10 The United
Kingdom has indicated an interest in allowing individuals to use directto-consumer DNA testing to better inform themselves about their
genetic risks. 211 Parents in the United Kingdom may face difficulty
advancing this argument because donor-conceived children can now
receive information relating to their donor as early as sixteen years of
age, 212 unlike donor-conceived children in the United States. Parents in
both jurisdictions, however, could argue that waiting this long for
important health information is unreasonable.
Courts in the United States and United Kingdom should consider
the fact-specific situation of the donor-conceived child's health when the
parents pursue direct-to-consumer DNA testing. This approach would
turn on the difference between symptomatic and asymptomatic minors.
With symptomatic minors, genetic information can be a useful tool in
the diagnosis and treatment of a health condition. 2 13 On the other hand,
for asymptomatic minors, access to genetic information and the
corresponding results could be postponed until the minor could
participate in the decision-making process. 214 Without the presence of
symptoms of illness, parental medical-decision-making abilities may not
be as strong as when a minor child is experiencing abnormalities or
illness.
Finally, courts in the United States and the United Kingdom may
also consider the relative ease of direct-to-consumer DNA testing when
determining whether parents should be authorized to genetically test
(Sept. 11, 2019), https://www.statnews.com/2019/09/11/consumer-dna-tests-sperm-donoranonymity/ (explaining how anonymity plays a role in the number of sperm donors).
207. See id.
208. FDA Press Release, supra note 171.
209. See Newmark, 588 A.2d at 1116.
210. Roberts & Rincon, supra note 168.
211. Id.
212. Hellman & Cohen, supra note 145.
213. Howard et al., supra note 186, at 1122.
214. Id.
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their donor-conceived children despite the anonymity regulations in
place. Here, parents of donor-conceived, minor children could argue that
this type of testing is noninvasive, often only requiring a sample of

saliva. 2 15 Courts have often factored in the difficulty of the medical
procedure when deciding whether to allow or discontinue medical
treatment for minor children. 216 Direct-to-consumer DNA testing is not
a cure or treatment for a medical issue, but it is a painless procedure
that allows parents to obtain important medical information about their
donor-conceived child in furtherance of the care and rearing of that
child. 2 17
Though regulations within the fertility industry are more expansive
in the United Kingdom than in the United States, no system is perfect.
As recently as the summer of 2018, warnings circulated in the United
Kingdom concerning seventeen British sperm donors who had fathered
more than five hundred children and likely had been passing on
defective DNA. 218 Currently, clinics are not mandated to screen donors
for genes such as BRCA1/2, genes which increase the risk of ovarian and
breast cancer. 219 In the United States, the use of direct-to-consumer
DNA tests exposed a number of doctors who used their own sperm to
impregnate patients without the patients' consent. 220 To add insult to
injury, NW Cryobank is facing another issue regarding a donor. On
September 1, 2020, NW Cryobank issued an email to its consumers that
donors 518 and 901A were the same person, resulting in thirty-six
births worldwide. 22 1 These realities illustrate the vast amount of
information genetic testing provides and exposes to the public without
interference from traditional healthcare regulations, and how genetic
testing can help keep the international fertility industry more
accountable. The transparency of direct-to-consumer DNA tests enables
215. Direct-to-Consumer Tests, supranote 160.
216. Parham, 442 U.S. at 602.
217. See What are the Benefits and Risks of Direct-to-Consumer Genetic Testing?,
MEDLINEPLUS, https://medlineplus.gov/genetics/understanding/dtcgenetitesting/dtcrisksbenefits/
(last visited Mar. 12, 2021).
218. Sarah Knapton, 500 Children Born to Just 17 Sperm Donors, TELEGRAPH (May 7,
2018), https://www.telegraph.co.uk/science/2018/05/06/17-british-sperm-donors-have-fathered500-children-figures-show/.
219. Id.
220. Jody L. Madeira et al., Against Seminal Principles:Ethics, Hubris, and Lessons to
Learn from Illicit Inseminations, 110 FERTILITY & STERILITY 1003, 1003 (2018); see also
Lauren Bavis, Conceived Through Fertility Fraud,'She Now Needs Fertility Treatment,
LANCASTERONLINE
(Jan.
28,
2020,
10:00
PM),
https://lancasteronline.com/news/health/conceived-through-fertility-fraud-she-now-needsfertility-treatment/article_3422fc 18-41d5-11 ea-853e-8b54a883c726.html.
221. Letter from Leora Westbrook, General Manager, NW Cryobank, to NW Cryobank
Clients (Sept. 1, 2020) (on file with author).
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families to get answers to questions they may not even have asked and
may never have been able to discover on their own.
CONCLUSION

While weighing the privacy concerns of donors, the benefits
resulting from allowing parents to use DNA testing seemingly outweigh
the costs. Despite anonymity agreements that promise donors privacy,

the way technology has advanced has dispelled any belief in remaining
a completely anonymous individual for donor purposes. Further,
without consistent international fertility regulations relating to the
testing of donor reproductive material, parents should be authorized to
conduct genetic testing in the best interest of the health of their minor
child. The low cost and convenience of direct-to-consumer DNA testing
allow parents and individuals of varying socioeconomic classes to learn
important information about themselves and their loved ones. The
United States does not have a national registry that tracks children
born through ART treatment, nor does it have a federal registry
containing donor information. 222 Though other countries, like the
United Kingdom, have more structured regulations, there are still
issues.

Regardless of the regulatory regime in place, it is unlikely that
parents will ever be free of fears and health issues related to the
procedures used to conceive. Therefore, it is necessary to allow parents
to exercise their right to make decisions in the best interests of their
children. This includes deciding whether their donor-conceived child
should undergo genetic testing.
Additionally, continued adherence to anonymity contracts set in
place by fertility clinics may enable misconduct to continue to occur and
could subject children and families to unnecessary harm. These are
public interest concerns that courts should acknowledge when
considering redress against parents of donor-conceived children who
breach clinic anonymity agreements.
If parents are authorized to send their donor-conceived child's DNA
to direct-to-consumer DNA testing companies like 23andMe, it will be
important to establish and implement a new standard of privacy for
donors who do not wish to be contacted. The fear of losing a significant
number of potential donors due to the loss of anonymity is legitimate. 223
Currently, there is no internationally recognized forum where donors
222. Rene Almeling, The Unregulated Sperm Industry, N.Y. TIMES (Nov. 30, 2013),
https://www.nytimes.com/2013/12/01/opinion/sunday/the-unregulated-spermindustry.html.
223. Knapton, supra note 218.
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and donor-conceived children connect, despite the potentially global
nature of baby-making.
I suggest creating an international forum to enable donors and
donor-conceived children and siblings to connect, if they choose to do so.
In this forum, a donor would register and could select an option to be
contacted. If a parent or donor-conceived child identifies the donor
within the international forum and notes an openness to connect, there
would be an opportunity for contact. If the donor registered in the forum
as not open to contact, parents and donor-conceived individuals would
clearly know that contact was not welcome. In doing so, donors and
potential future donors would not live in fear of having forced contact
with any resulting children born from their reproductive material.

Nonetheless, the donor-conceived children and their parents could
always have access to the genetic information.
The furtherance of international fertility regulation through global
registries could also enhance the transparency of fertility clinics. Directto-consumer DNA testing has exposed fertility fraud, an increasingly
known phenomenon appearing globally, 224 with cases ranging from

Indiana to the Netherlands. 225 An international registry to track all
types of fertility treatments and donor-conceived children would assist
with the exposure of fertility misconduct-especially with clinics or
individuals who choose to transport reproductive material to different
jurisdictions in lieu of abiding by the regulations of their jurisdiction.
Individuals would have the ability to track half-siblings or donors who
reside in other areas of the world, further advancing the ability for
individuals to know more about themselves and others who share their
genetic information.
There is plenty of room for improvement in the fertility industry.

Countries, like the United Kingdom, that allow donor-conceived
children to access their donor's identifying information at an earlier age
have made significant regulation advancements in comparison to
countries like the United States, which currently still allows clinics to
promise life-long anonymity to the detriment of many donors and donorconceived individuals. The United States could consider implementing
fertility regulations that eliminate anonymity provisions once a donorconceived child reaches a certain age, but regulators are unlikely to

224. See generally Madeira et al., supra note 220, at 1004 ("[G]enetic testing could still
reveal other unethical negligent or intentional conduct, such as the use of nonconsenting
patients' gametes or embryos to impregnate others. This misconduct occurred in 1995 at
the Center for Reproductive Health at the University of California, Irvine, costing the
university tens of millions of dollars in settlements and legal fees.").
225. Id. ('Netherlands media reported that a physician allegedly engaged in such
conduct as recently as 2010 or 2011....").
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implement this kind of regulation due to the drastic impact it would
have on the profit-turning fertility industry. 226 Instead, for now, I
suggest that reproductive healthcare professionals, parents, and donors
in all countries be made aware of the current limits of privacy with the
growth of the direct-to-consumer DNA testing market. 227 I also suggest
that clinics not be given the option to seek redress against consumers of
direct-to-consumer DNA tests. The increased use of DNA tests that

identify ancestry and genetic information is not likely to waiver, and
clinics that continue to promise donor anonymity seemingly do so in bad
faith.
Lastly, I suggest that countries' fertility regulations recognize the
interest of parental, medical decision-making. After a child is born with
the assistance of donor reproductive material, it seems inequitable for
fertility clinics to maintain control over decisions parents make related
to the health of their donor-conceived children. This is especially true
for children who were not signed parties to the agreements between the
clinics, donors, and future parents. Fit parents are presumed to be
acting in the best interests of their children; choosing to be informed
about the genetic information of a child who was conceived in a quickly
advancing industry seems to be the very embodiment of acting in the
child's best interest.
More research is needed in the area of direct-to-consumer DNA
testing of donor-conceived children. One additional area of research that
would build on the topic of this note is a minor's right to obtain or refuse
genetic testing herself. 228 This would likely involve the mature minor
doctrine, 229 and could implicate the tension between fertility clinics'
anonymity agreements and donors' privacy. In this instance, the minor
wanting (or refusing) genetic testing was not a party to the anonymity

agreement signed by her parents, though the agreement undoubtedly
involves the minor. Some United States jurisdictions have enacted

226. See generally Ouellette et al., supra note 72 (explaining the difference in
government structure of the United States and United Kingdom that would likely prevent
the United States from implementing a system similar to the United Kingdom).
227. An important aspect of this involves informed consent, a topic not addressed by this
paper. See generally Madeira et al., supra note 220 (explaining aspects of informed
consent).
228. See generally Ellen W. Clayton, How Much Control Do Children and Adolescents
Have Over Genomic Testing, Parental Access to Their Results, and Parental
Communication of Those Results to Others?, 43 J.L. MED. ETHICS 538 (2016) (discussing
implications of minors and DTC DNA testing).
229. The mature minor doctrine refers to an American rule of law allowing a minor to
opt in or out of a medical treatment if she has the necessary. The MatureMinor Doctrine,
USLEGAL.CoM, https://healthcare.uslegal.com/treatment-of-minors/the-mature-minor-doctrine/
(last visited Mar. 12, 2021).
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legislation that requires parental consent for a minor to have genetic
testing. 230

Another area for additional research relates to the various direct-toconsumer DNA testing regulations in countries worldwide. 231 As some
countries have banned direct-to-consumer DNA testing, 232 parents of
donor-conceived children in these countries may face more setbacks
when they are trying to discover their minor child's genetic information.
It would be useful to know the legal setbacks involved in the pursuit of
that genetic information. Additionally, it would be useful to study the
legal ramifications of individuals who travel to other jurisdictions to use
direct-to-consumer DNA testing.

For better or worse, direct-to-consumer DNA testing is available
throughout most of the world and is likely here to stay. As more
individuals utilize fertility assistance and other technological advances,
the lack of uniformity regarding donor anonymity has become extremely
problematic. Clinics should not have the ability to hide from the reality
that technological advancements have dispelled the illusion of donor
anonymity. It is time to face the truth, no matter how hard it hurts
profits. Parents like Danielle Teuscher should not be faced with
retribution when acting in the best interests of their donor-conceived
children. Instead, fertility clinics should openly and definitively declare
that donor anonymity is no longer feasible and make amendments to
current practices. Though difficult, it is possible to rethink and
restructure the fertility industry as it relates to the rights of donorconceived children and their parents.

230. ARIz. REV. STAT. ANN. §§ 1-602(A)(5), (8), 12-2803 (2020); OKLA. STAT. ANN. tit. 25,
§ 2002 (2020); see also 16 DEL. CODE § 1226 (2014).
231. See generally L. Kalokairinou et al., Legislation of Direct-to-Consumer Genetic
Testing in Europe: A FragmentedRegulatory Landscape, 9 J. COMMUNITY GENETICS 117
(2017) (analyzing DTC genetic testing regulations in Europe).
232. Id. at 117.

